Pliant Therapeutics, Inc. SEC filings PLRX

Pliant Therapeutics, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jul 20, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.

Pliant Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 2, 2026 Oct 1, 2026
3 Initial insider ownership Oct 2, 2026 Sep 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
3 Initial insider ownership Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
3 Initial insider ownership Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
8-K Current report
Officer or director change
Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 11, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 11, 2026
4 Insider transaction Apr 17, 2026 Apr 17, 2026
4 Insider transaction Apr 17, 2026 Apr 17, 2026
4 Insider transaction Apr 17, 2026 Apr 17, 2026
4 Insider transaction Apr 17, 2026 Apr 17, 2026
8-K Current report
Officer or director change
Apr 17, 2026 Apr 14, 2026
EFFECT Filing Apr 6, 2026 —
CORRESP Letter to the SEC Apr 2, 2026 —
UPLOAD Letter from the SEC Apr 2, 2026 —
S-3 Shelf registration Mar 30, 2026 —
8-K Current report
Other events
Mar 30, 2026 Mar 27, 2026
S-8 Employee stock plan registration Mar 11, 2026 —
8-K Current report
Results of operations
Mar 11, 2026 Mar 11, 2026
10-K Annual report Mar 11, 2026 Dec 31, 2025
8-K Current report
Material agreement, Change to shareholder rights
Mar 3, 2026 Mar 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 22, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
3 Initial insider ownership Dec 22, 2025 Dec 10, 2025
8-K Current report
Officer or director change
Dec 16, 2025 Dec 10, 2025
8-K Current report
Officer or director change
Dec 8, 2025 Dec 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Officer or director change
Oct 24, 2025 Oct 20, 2025
8-K Current report
Agreement ended
Oct 20, 2025 Oct 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 9, 2025 Jun 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
May 1, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 5, 2025
PRER14A Filing Apr 11, 2025 —
PRE 14A Preliminary proxy statement Apr 10, 2025 Dec 31, 2024
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 13, 2025 Mar 12, 2025
8-A12B Filing Mar 13, 2025 —
SCHEDULE 13D Ownership over 5% (active) Mar 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 7, 2025 —
S-8 Employee stock plan registration Mar 3, 2025 —
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Other events
Feb 13, 2025 Feb 13, 2025
8-K Current report
Other events
Feb 10, 2025 Feb 7, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
144 Notice of proposed sale Jan 22, 2025 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Oct 4, 2024 —
8-K Current report
Bylaw or fiscal year change
Sep 27, 2024 Sep 24, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Other events
Jul 15, 2024 Jul 15, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 12, 2024 Jul 10, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jul 11, 2024 Jul 9, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
3 Initial insider ownership Jun 17, 2024 Jun 13, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2024 Jun 13, 2024
8-K Current report
Other events
May 14, 2024 May 14, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
4 Insider transaction May 6, 2024 May 2, 2024
DEFA14A Additional proxy material Apr 22, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt, Other events
Mar 12, 2024 Mar 11, 2024
S-8 Employee stock plan registration Feb 27, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G Ownership over 5% (passive) Feb 8, 2024 —
8-K Current report
Other events
Feb 5, 2024 Feb 4, 2024
SC 13G Ownership over 5% (passive) Jan 25, 2024 —
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 24, 2024 Jan 23, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Material agreement, Agreement ended, New debt
Oct 3, 2023 Sep 28, 2023
8-K Current report
Other events
Sep 26, 2023 Sep 26, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
4 Insider transaction Aug 7, 2023 Aug 3, 2023
144 Notice of proposed sale Aug 3, 2023 —
4 Insider transaction Jul 21, 2023 Jul 20, 2023
144 Notice of proposed sale Jul 20, 2023 —
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 19, 2023 Jul 17, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jun 14, 2023 Jun 13, 2023
4 Insider transaction Jun 12, 2023 Jun 9, 2023
4 Insider transaction Jun 8, 2023 Jun 7, 2023
4 Insider transaction Jun 8, 2023 Jun 7, 2023
4 Insider transaction Jun 8, 2023 Jun 7, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PLRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1746473

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.